Lipoprotein(a) as a marker for coronary heart disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  British journal of clinical practice. Supplement

• Publication date

  1994-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 19496273
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• The gene for the Lp(a)-specific glycoprotein is closely linked to the gene for plasminogen on chromosome 6

  2004cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Plasma Lp(a), apolipoprotein(a) isoforms and acute myocardial infarction in men and women: a case-control study in the Jerusalem population.

  1993cited by this paper
• Lipoprotein[a] as a risk factor for preclinical atherosclerosis.

  1993cited by this paper
• Elevated lipoprotein(a) is lowered by a cholesterol synthesis inhibitor in a normocholesterolaemic patient with premature myocardial infarction.

  1993cited by this paper
• Immunostaining of human autopsy aortas with antibodies to modified apolipoprotein B and apoprotein(a).

  1993cited by this paper
• The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Plasma lipoprotein and apolipoprotein levels in Taipei and Framingham.

  1993cited by this paper
• Coronary artery disease risk predicted by plasma concentrations of high-density lipoprotein cholesterol, apolipoprotein AI, apolipoprotein B, and lipoprotein(a) in a general Chinese population.

  1993cited by this paper
• Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study.

  1993cited by this paper
• In vivo fate and scavenger receptor recognition of oxidized lipoprotein[a] isoforms in rats.

  1992cited by this paper
• Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages.

  1992cited by this paper
• Atherogenesis in transgenic mice expressing human apolipoprotein(a)

  1992cited by this paper
• Lack of association between lipoprotein (a) concentrations and coronary heart disease mortality in diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy.

  1992cited by this paper
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

  1991cited by this paper
• N-acetylcysteine and lipoprotein.

  1991cited by this paper
• Lipoprotein(a) reduction by N-acetylcysteine.

  1991cited by this paper
• Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women.

  1991cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Lipoprotein(a). A unique risk factor for atherothrombotic disease.

  1990cited by this paper
• Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia.

  1990cited by this paper
• Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice.

  1990cited by this paper
• The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.

  1990cited by this paper
• Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.

  1989cited by this paper
• Lipoprotein a inhibits streptokinase-mediated activation of human plasminogen.

  1989cited by this paper
• HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels.

  1989cited by this paper
• Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

  1989cited by this paper
• Unchanged serum lipoprotein (a) concentrations with lovastatin.

  1989cited by this paper
• Lipoprotein (a) and plasminogen are immunochemically related.

  1988cited by this paper
• The apolipoprotein(a) gene resides on human chromosome 6q26–27, in close proximity to the homologous gene for plasminogen

  1988cited by this paper
• Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

  1988cited by this paper
• Apolipoproteins (a), AI, and B and parental history in men with early onset ischaemic heart disease.

  1988cited by this paper
• Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

  1985cited by this paper
• Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

  1985cited by this paper
• Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol.

  1984cited by this paper
• Protein composition of Lp(a) lipoprotein from human plasma

  1983cited by this paper
• Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

  1983cited by this paper
• Human plasma lipoprotein [a]. Structural properties.

  1983cited by this paper
• Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.

  1982cited by this paper
• Structural and Functional Changes of Rhesus Serum Low Density Lipoproteins During Cycles of Diet‐Induced Hypercholesterolemia

  1982cited by this paper
• Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts

  1981cited by this paper
• Uptake of Lp (a) lipoprotein by cultured fibroblasts.

  1981cited by this paper
• Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor

  1981cited by this paper
• Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii.

  1978cited by this paper
• Serum lipids in angiographically assessed coronary atherosclerosis.

  1978cited by this paper
• Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease

  1975cited by this paper
• Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease

  1974cited by this paper

• Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a)

  2016influential citation
• Author Queries

  2016cites this paper
• Neutrophil gelatinase-associated lipocalin as diagnostic and prognostic tool for cardiovascular disease and heart failure.

  2013cites this paper
• Lipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia.

  2011cites this paper
• Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care.

  2010cites this paper
• Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study.

  2009cites this paper
• Lipoproteína (a) em pacientes portadores de doença arterial obstrutiva periférica e/ou diabetes mellitus tipo 2

  2008cites this paper
• Effect of pioglitazone on atherogenic outcomes in type 2 diabetic patients: a comparison of responders and non-responders.

  2007cites this paper
• Lipoprotein(a) as an Emerging Risk Factor for Atherothrombosis

  2007cites this paper
• Lipoproteína(a) e inibição da fibrinólise na doença arterial coronariana

  2006cites this paper
• Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: recent advances and future directions.

  2003cites this paper
• Does lipoprotein(a) inhibit elastolysis in abdominal aortic aneurysms?

  2003cites this paper
• Elevated lipoprotein(a) with statin therapy.

  2000cites this paper
• Reply of the authors11February 10, 2000

  2000cites this paper
• Reply of the authors1

  2000cites this paper
• Plasma lipids, lipoproteins and apolipoproteins and sudden cardiac death

  1999cites this paper
• Biologic markers as predictors of cardiovascular disease.

  1998cites this paper